• Mitsubishi Tanabe Pharma to buy NeuroDerm for $1.1bn pharmaceutical-technology
    July 27, 2017
    Japan’s Mitsubishi Tanabe Pharma (MTPC) has entered a new definitive agreement to acquire all of the outstanding shares of Israel-based pharmaceutical company NeuroDerm for $1.1bn in cash.
PharmaSources Customer Service